Log in

NASDAQ:DOXAmdocs Stock Price, Forecast & News

$62.58
+0.48 (+0.77 %)
(As of 08/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$62.05
Now: $62.58
$62.70
50-Day Range
$58.21
MA: $60.38
$63.19
52-Week Range
$44.05
Now: $62.58
$77.29
Volume475,768 shs
Average Volume964,947 shs
Market Capitalization$8.43 billion
P/E Ratio17.15
Dividend Yield2.11%
Beta0.67
Amdocs Limited, through its subsidiaries, provides software and services to the communications, pay TV, entertainment, and media industry service providers worldwide. The company offers amdocsONE a line of services designed for various stages of a service provider's lifecycle, including planning, delivery, implementation, and ongoing support, as well as consumer experience and monetization, media and digital, enterprise and connected society, service-driven network, and services and agile operation solutions. It also provides managed, quality engineering, data and intelligence, cloud enablement, digital business operation, autonomous network service assurance, and advisory services. In addition, the company offers mobile financial services, which enable service providers and financial institutions to serve financially underserved customer segments; revenue guard services designed to detect and resolve revenue leakage, fraud, and cyber fraud; and the BriteBill, a multi-channel bill presentment platform focused on contextual and personalized customer engagements. Further, it provides advertising and media services for media publishers, TV networks, video streaming providers, advertising agencies, and service providers. The company was founded in 1988 and is headquartered in Chesterfield, Missouri.
Read More
Amdocs logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 2.9Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.28 out of 5 stars


Industry, Sector and Symbol

Industry Custom computer programming services
Sub-IndustryIT Consulting & Other Services
Current SymbolNASDAQ:DOX
CUSIPG0260210
Phone1 314 212 7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.09 billion
Cash Flow$5.74 per share
Book Value$26.28 per share

Profitability

Net Income$479.45 million

Miscellaneous

Employees24,516
Market Cap$8.43 billion
Next Earnings Date8/5/2020 (Confirmed)
OptionableOptionable
$62.58
+0.48 (+0.77 %)
(As of 08/3/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive DOX News and Ratings via Email

Sign-up to receive the latest news and ratings for DOX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Amdocs (NASDAQ:DOX) Frequently Asked Questions

How has Amdocs' stock been impacted by COVID-19 (Coronavirus)?

Amdocs' stock was trading at $61.42 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, DOX stock has increased by 1.9% and is now trading at $62.58.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Amdocs?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Amdocs
.

When is Amdocs' next earnings date?

Amdocs is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020.
View our earnings forecast for Amdocs
.

How can I listen to Amdocs' earnings call?

Amdocs will be holding an earnings conference call on Wednesday, August 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Amdocs' earnings last quarter?

Amdocs Limited (NASDAQ:DOX) issued its earnings results on Thursday, May, 7th. The technology company reported $1.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.06 by $0.02. The technology company had revenue of $1.05 billion for the quarter, compared to the consensus estimate of $1.04 billion. Amdocs had a return on equity of 16.03% and a net margin of 11.98%. Amdocs's revenue was up 2.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.06 EPS.
View Amdocs' earnings history
.

How often does Amdocs pay dividends? What is the dividend yield for Amdocs?

Amdocs announced a quarterly dividend on Thursday, May 7th. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.327 per share on Friday, July 24th. This represents a $1.31 dividend on an annualized basis and a dividend yield of 2.09%. The ex-dividend date of this dividend is Monday, June 29th.
View Amdocs' dividend history
.

What guidance has Amdocs issued on next quarter's earnings?

Amdocs issued an update on its third quarter earnings guidance on Thursday, May, 7th. The company provided earnings per share (EPS) guidance of $1.00 to $1.08 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.16. The company issued revenue guidance of $990 million to $1.040 billion, compared to the consensus revenue estimate of $1.05 billion.

What price target have analysts set for DOX?

5 equities research analysts have issued 12-month price objectives for Amdocs' shares. Their forecasts range from $72.00 to $85.00. On average, they expect Amdocs' share price to reach $76.40 in the next twelve months. This suggests a possible upside of 22.1% from the stock's current price.
View analysts' price targets for Amdocs
.

Has Amdocs been receiving favorable news coverage?

Media stories about DOX stock have trended somewhat positive on Tuesday, according to InfoTrie Sentiment. The research firm scores the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Amdocs earned a media sentiment score of 1.8 on InfoTrie's scale. They also assigned news stories about the technology company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future.
View the latest news about Amdocs
.

Are investors shorting Amdocs?

Amdocs saw a decrease in short interest during the month of July. As of July 15th, there was short interest totaling 2,590,000 shares, a decrease of 9.1% from the June 30th total of 2,850,000 shares. Based on an average daily trading volume, of 890,300 shares, the short-interest ratio is currently 2.9 days. Approximately 1.9% of the company's stock are short sold.
View Amdocs' Current Options Chain
.

Who are some of Amdocs' key competitors?

What other stocks do shareholders of Amdocs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include AbbVie (ABBV), Comcast (CMCSA), AT&T (T), Walt Disney (DIS), Gilead Sciences (GILD), Home Depot (HD), Intel (INTC), Pfizer (PFE), Verizon Communications (VZ) and Cisco Systems (CSCO).

Who are Amdocs' key executives?

Amdocs' management team includes the following people:
  • Mr. Joshua Sheffer, Pres & CEO (Age 59)
  • Ms. Tamar Rapaport-Dagim, CFO & COO (Age 48)
  • Mr. Matthew E. Smith, Sec. & Head of Investor Relations (Age 47)
  • Mr. Gary Miles, Chief Marketing Officer
  • Darcy Antonellis, Head of Amdocs Media

What is Amdocs' stock symbol?

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Who are Amdocs' major shareholders?

Amdocs' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Robeco Institutional Asset Management B.V. (1.32%), First Trust Advisors LP (0.82%), Wedge Capital Management L L P NC (0.63%), CWM LLC (0.41%), PGGM Investments (0.32%) and Harel Insurance Investments & Financial Services Ltd. (0.24%).

Which institutional investors are selling Amdocs stock?

DOX stock was sold by a variety of institutional investors in the last quarter, including Denali Advisors LLC, Robeco Institutional Asset Management B.V., Raymond James & Associates, Grandfield & Dodd LLC, Stone Ridge Asset Management LLC, Envestnet Asset Management Inc., Brinker Capital Inc., and CENTRAL TRUST Co.

Which institutional investors are buying Amdocs stock?

DOX stock was purchased by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, CWM LLC, UNIVEST FINANCIAL Corp, Exane Asset Management, Anderson Fisher LLC, Sciencast Management LP, Cambiar Investors LLC, and NN Investment Partners Holdings N.V..

How do I buy shares of Amdocs?

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Amdocs' stock price today?

One share of DOX stock can currently be purchased for approximately $62.58.

How big of a company is Amdocs?

Amdocs has a market capitalization of $8.43 billion and generates $4.09 billion in revenue each year. The technology company earns $479.45 million in net income (profit) each year or $4.07 on an earnings per share basis. Amdocs employs 24,516 workers across the globe.

What is Amdocs' official website?

The official website for Amdocs is www.amdocs.com.

How can I contact Amdocs?

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]

This page was last updated on 8/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.